MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with L

Lamivudine

Lamivudine 100mg tablets

Use with caution

Stability notes for Lamivudine 100mg tablets

Protect from light. No stability data in MCAs available.

Provenance

This recommendation is based on the products Zeffix 100mg tablets (GlaxoSmithKline UK) and lamivudine 100mg tablets (Milpharm Aurobindo Pharma - Milpharm Ltd).

Suppliers (9) of Lamivudine 100mg tablets
Lamivudine 100mg tablets (A A H Pharmaceuticals Ltd)
Lamivudine 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Lamivudine 100mg tablets (Amarox Ltd)
Lamivudine 100mg tablets (Milpharm Ltd)
Lamivudine 100mg tablets (Sigma Pharmaceuticals Plc)
Lamivudine 100mg tablets (Viatris UK Healthcare Ltd)
Zeffix 100mg tablets (CST Pharma Ltd)
Zeffix 100mg tablets (GlaxoSmithKline UK Ltd)
Zeffix 100mg tablets (Sigma Pharmaceuticals Plc)

Lamivudine 150mg tablets

Use with caution

Stability notes for Lamivudine 150mg tablets

Protect from light. No stability data in MCAs available.

Provenance

This recommendation is based on the products Epivir 150mg tablets (ViiV Healthcare UK Ltd) and lamivudine 150mg tablets (Milpharm Aurobindo Pharma - Milpharm Ltd).

Suppliers

Epivir 150mg tablets (ViiV Healthcare UK Ltd)
Lamivudine 150mg tablets (Milpharm Ltd)
Lamivudine 150mg tablets (Viatris UK Healthcare Ltd)

Lamivudine 300mg tablets

Use with caution

Stability notes for Lamivudine 300mg tablets

Protect from light. No stability data in MCAs available.

Provenance

This recommendation is based on the products Epivir 300mg tablets (ViiV Healthcare UK Ltd) and lamivudine 300mg tablets (Milpharm Aurobindo Pharma - Milpharm Ltd).

Suppliers (4) of Lamivudine 300mg tablets
Epivir 300mg tablets (ViiV Healthcare UK Ltd)
Lamivudine 300mg tablets (A A H Pharmaceuticals Ltd)
Lamivudine 300mg tablets (Milpharm Ltd)
Lamivudine 300mg tablets (Viatris UK Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.